Evidence map›Paper›PMID 28040776›Full record

ArticleG3 (Bethesda, Md.)2017

Genome-Wide Screen for Haploinsufficient Cell Size Genes in the Opportunistic Yeast

Julien Chaillot, Michael A Cook, Jacques Corbeil, Adnane Sellam

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. TheCells · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. AJournal of fungi (Basel, Switzerland) · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Role of Protein Mannosylation in theFrontiers in microbiology · 2019
    Article
  13. Article
  14. Controlling organism size by regulating constituent cell numbers.Proceedings of the ... IEEE Conference on Decision & Control. IEEE Conference on Decision & Control · 2018
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Julien ChaillotInfectious Diseases Research Centre, Centre Hospitalier Universitaire (CHU) de Québec Research Center, Université Laval, Quebec City, Quebec, Canada.
Michael A CookCentre for Systems Biology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, G1V 4G2 Canada.
Jacques CorbeilInfectious Diseases Research Centre, Centre Hospitalier Universitaire (CHU) de Québec Research Center, Université Laval, Quebec City, Quebec, Canada.ORCID 0000-0002-9973-2740
Adnane SellamInfectious Diseases Research Centre, Centre Hospitalier Universitaire (CHU) de Québec Research Center, Université Laval, Quebec City, Quebec, Canada adnane.sellam@crchudequebec.ulaval.ca adnane.sellam@gmail.com.ORCID 0000-0002-0506-7752
Université Laval · CAMount Sinai Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most critical but still poorly understood aspects of eukaryotic cell proliferation is the basis for commitment to cell division in late G1 phase, called Start in yeast and the Restriction Point in metazoans. In all species, a critical cell size threshold coordinates cell growth with cell division and thereby establishes a homeostatic cell size. While a comprehensive survey of cell size genetic determinism has been performed in the saprophytic yeasts

Indexed as

Cell SizeAmino Acid SequenceCandida albicansCell CycleCell ProliferationFungal ProteinsGenome, FungalHaploinsufficiencyFungal ProteinsCandida albicanscell sizehaploinsufficiencyStart control

Identifiers

PMID28040776
PMCPMC5295585
OpenAlexW2580026892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.